Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Return on Assets (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Return on Assets for 8 consecutive years, with 0.59% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 7.0% to 0.59% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.59%, a 7.0% increase, with the full-year FY2024 number at 0.63%, down 21.0% from a year prior.
  • Return on Assets was 0.59% for Q3 2025 at Whitehawk Therapeutics, down from 0.47% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q2 2021 to a low of 1.0% in Q2 2022.
  • A 5-year average of 0.53% and a median of 0.48% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: tumbled -91bps in 2022, then soared 62bps in 2023.
  • Whitehawk Therapeutics' Return on Assets stood at 0.67% in 2021, then surged by 53bps to 0.32% in 2022, then tumbled by -51bps to 0.48% in 2023, then crashed by -69bps to 0.82% in 2024, then increased by 27bps to 0.59% in 2025.
  • Per Business Quant, the three most recent readings for WHWK's Return on Assets are 0.59% (Q3 2025), 0.47% (Q2 2025), and 0.39% (Q1 2025).